T S R Inc (TSRI) 7.69 $TSRI Robert A. Esernio Resigns

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...